Galleu et al. showed that MSCs used to treat graft-vs.-host disease (GvHD) undergo apoptosis in a perforin-dependent mechanism by recipient cytotoxic cells, and this process is required for MSC-mediated immunosuppression (201). This evidence concerns the gene PRF1 and graft versus host disease.